"The guest highlighted Biohaven as a prime example of a highly profitable setup where merger arbitrage, a spin-off, and insider buying converged."

"The guest argued that select large-cap healthcare and pharmaceutical companies are deeply mispriced due to temporary patent cliffs and political overhangs, offering strong cash flows and high dividend yields."

"Host Josh Brown argued that the isolated destruction of the software sector is highly bullish for the broader market, signaling a healthy capital rotation into undisrupted sectors."

"The guest argued that the most effective way for corporate leaders to counter political pressure from the Trump administration is through private, collective industry action rather than public grandstanding or individual compliance."